期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Ramucirumab as a second-line treatment for hepatocellular carcinoma: reaching out further to patients with elevated alpha-fetoprotein 被引量:1
1
作者 Edoardo G.Giannini Franco Trevisani 《Hepatobiliary Surgery and Nutrition》 SCIE 2019年第5期515-518,共4页
Hepatocellular carcinoma(HCC)occurs at a rate of 3-5%per year in patients with compensated cirrhosis,and itoften represents the first disease complication and themain cause of death in these patients(1).Surveillance f... Hepatocellular carcinoma(HCC)occurs at a rate of 3-5%per year in patients with compensated cirrhosis,and itoften represents the first disease complication and themain cause of death in these patients(1).Surveillance forHCC is recommended by all liver disease associations,as it increases patient survival mainly as a result of earlydiagnosis of the tumour,allowing most patients to conveyto curative treatments(2,3). 展开更多
关键词 diagnosis treatment CURATIVE DEATH
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部